Patented drugs market size was valued at $814.5 billion in 2022, and is estimated to reach $1456.5 billion by 2032, growing at a CAGR of 6% from 2023 to 2032. A patent is a form of legal protection granted by a government authority to inventors for their novel inventions. Various government authorities such as U.S. Patent and Trademark Office (USPTO), European Patent Office (EPO), or China National Intellectual Property Administration (CNIPA) grant legal protection and exclusivity to innovative medicines developed by pharmaceutical companies is called as patented drugs.
๐๐ข๐ฌ๐ญ ๐จ๐ ๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ :
AbbVie Inc., Pfizer Inc., Johnson & Johnson, Astellas Pharma Inc., Biogen, Bayer AG, Novartis AG, Amgen Inc., AstraZeneca plc, F. Hoffmann-La Roche AG
๐ ๐จ๐ซ ๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ง๐ช๐ฎ๐ข๐ซ๐ฒ https://www.alliedmarketresearch.com/purchase-enquiry/111477
On the basis of dosage form, the liquid segment dominated the market in 2022, and is the fastest growing segment during the forecast period. This is attributed to easy availability and accessibility of liquid patented drugs and increase in product approvals for liquid drug products.
On the basis of indication, the cancer segment held the highest patented drugs market share in 2022. This is attributed to increase in prevalence of cancer and development of novel cancer treatment during the forecast period. However, the others segment is expected to register fastest growth in the patented drugs market forecast period, owing to increase in R&D activities to develop new treatments for rare diseases and Parkinsonโs disease.
On the basis of distribution channel, the drug stores and retail pharmacies segment dominated the global market in 2022 and is the fastest growing segment during the forecast period, owing to easy availability of patented drugs through drugs stores and increase in sale of patented drugs.
Region wise, North America held the highest patented drugs market share in 2022, and is expected to maintain its lead during the forecast period owing to increase in prevalence of chronic diseases, rise in adoption of patented drugs, easy accessibility of medications, and strong presence of market players. However, Asia-Pacific is expected to exhibit the fastest growth during the forecast period, owing to rise in patent application filing by Japan and China, increase in prevalence of diabetes, and development of pharmaceutical industry.
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ https://www.alliedmarketresearch.com/request-sample/111477
๐๐๐๐๐ ๐๐๐๐๐๐๐๐๐๐๐๐ ๐๐๐๐๐๐๐ ๐๐ ๐๐๐ ๐๐๐๐๐๐:
Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
Comprehensive quantitative and qualitative insights at segment and sub-segment level
Covid 19 impact trends and perspective
Granular insights at global/regional/country level
Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
Blanket coverage on competitive landscape
Winning imperatives
Exhaustive coverage on โStrategic Developmentsโ registered by leading players of the market
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of โMarket Research Reportsโ and โBusiness Intelligence Solutions.โ AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com